Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

ImazA.pdf (178.06 KB)

Document type

Article

Version

Published version

Publication date

2012-11-11

Publication license

cc by (c) Imaz et al., 2012
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/126488

Effectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.7448/IAS.15.6.18235

Abstract

Purpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results have been reported. We compared the effectiveness between NNRTI and PI/r as first-line cART fof HIV-1-infected patients with high pVL.

Subject

Infeccions per VIH, Antiretrovirals

Subject (English)

HIV infections, Antiretroviral agents

Citation

Collections

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

IMAZ, Arkaitz, et al. Effectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load. Journal of the International Aids Society. 2012. Vol. 15, num. 18235, pags. 147. [consulted: 8 of August of 2026]. Available at: https://hdl.handle.net/2445/126488

Export metadata

JSON - METS

Share record